APA (7th ed.) Citation

BJ, S., D, R., Z, S., EM, A., DA, B., K, H., . . . MD, S. (2026). Avasopasem manganese acts as both a radioprotector and a radiomitigator of radiation-induced acute or late effects. Frontiers in oncology, 16, 1761003. https://doi.org/10.3389/fonc.2026.1761003

Chicago Style (17th ed.) Citation

BJ, Sishc, et al. "Avasopasem Manganese Acts as Both a Radioprotector and a Radiomitigator of Radiation-induced Acute or Late Effects." Frontiers in Oncology 16 (2026): 1761003. https://doi.org/10.3389/fonc.2026.1761003.

MLA (9th ed.) Citation

BJ, Sishc, et al. "Avasopasem Manganese Acts as Both a Radioprotector and a Radiomitigator of Radiation-induced Acute or Late Effects." Frontiers in Oncology, vol. 16, 2026, p. 1761003, https://doi.org/10.3389/fonc.2026.1761003.